ArticleCNS neuroscience & therapeutics2024

In silico and in vitro analyses of a novel FoxO1 agonist reducing Aβ levels via downregulation of BACE1.

Ming-Ti Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.